लोड हो रहा है...
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
Platinum chemotherapy remains the cornerstone of treatment for epithelial ovarian cancer (OC) and Poly (ADP-ribose) polymerase inhibitors (PARPi) now have an established role as maintenance therapy. The mechanisms of action of these agents is, in many ways, complementary, and crucially reliant on th...
में बचाया:
| में प्रकाशित: | Cancers (Basel) |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
MDPI
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352566/ https://ncbi.nlm.nih.gov/pubmed/32560564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061607 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|